GlassScriptPhysician profile
Jordyn Conroy
NPI 1912535402
$3,040.95
in general payments reported to CMS, 2019-2025
12 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,427 · 2023: $645 · 2024: $566 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.47 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $1,370.65 | 2022-2025 | Remodulin, Tyvaso, Orenitram |
| Inari Medical, INC. | $1,146.77 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $247.90 | 2023 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $79.29 | 2023-2025 | Winrevair |
| Janssen Pharmaceuticals, INC | $56.89 | 2024 | Xarelto |
| Baxter Healthcare | $23.43 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.22 | 2022 | |
| Inogen, INC. | $21.08 | 2025 | |
| Pfizer INC. | $20.23 | 2022 | |
| Glaxosmithkline, LLC. | $16.44 | 2023 | Nucala |
| Melinta Therapeutics, LLC | $12.97 | 2023 | Vabomere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordyn Conroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.